Bortezomib in the management of multiple myeloma

Multiple myeloma (MM) is a B-cell malignancy characterized by clonal expansion of plasma cells within the bone marrow, the presence of a serum and/or urine monoclonal protein, lytic bone lesions, and anemia. On a cellular level, the disease is characterized by complex interactions between tumor cell...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Laubach, Jacob P, Mitsiades, Constantine S, Hideshima, Teru, Schlossman, Robert, Chauhan, Dharminder, Munshi, Nikhil, Ghobrial, Irene, Carreau, Nicole, Anderson, Kenneth C, Richardson, Paul G
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2009
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3004671/
https://ncbi.nlm.nih.gov/pubmed/21188129
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars